Skip to content
Luna Metabolic
Menu
Ranked #58 for women · Grade C

WellMedr review

A genuinely broad low-dose menu — eight microdose formulations, four of them oral, on top of both injectable molecules and a priced brand path — wrapped around a price you cannot pin down: the $59 and $99 headlines are conditional, and the rate you would actually be charged month to month appears nowhere before the medical intake.

Visit WellMedr Assume any provider we list may compensate us — we may earn a commission, at no cost to you. See our disclosure.
Semaglutide
$59/mo advertised, tied by the site's own banner to a 12-month plan; no month-to-month rate published ahead of the intake (brand Ozempic $1,399/mo month-to-month)
Tirzepatide
$99/mo advertised on the same unsettled terms, "same price regardless of dosage"; no month-to-month rate published (brand Zepbound $1,599/mo month-to-month)
Coverage
Not publicly listed
Brand-name
Yes

The Luna Fit scorecard

WellMedr scored on our six women's-health factors. See the methodology.

PCOS & hormonal suitability72/100
Clinical oversight & labs70/100
Price transparency54/100
Nationwide access74/100
Ongoing support80/100
Cancellation fairness52/100

What we like

  • A real low-dose line rather than a smaller pour of the standard plan: eight microdose formulations, four oral and four injectable, built on tirzepatide or semaglutide with NAD+, B12, inositol, methionine, L-carnitine or magnesium depending on the SKU — the needle-free half of that matters if injections are the thing that has kept you from starting
  • Both molecules plus an FDA-approved brand path priced on the same page — Ozempic from $1,399/mo and Zepbound from $1,599/mo, both month-to-month — so a woman whose clinician wants brand rather than compounded can see the cash cost without opening another tab
  • Tirzepatide is priced the same at every dose: "Same price regardless of dosage" is printed on that plan card, so titrating up to a dose that works does not raise the bill — the question a woman starting low should be asking, and one most of this ranking leaves unanswered
  • The compounding caveat sits on the pricing page rather than in a footer, in the company's own words: compounded medications "are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy", printed beside explicit thyroid C-cell tumor and medullary thyroid carcinoma warnings
  • Both ends of the supply chain are named. The telehealth consent is issued by OpenLoop Healthcare Partners, PC and lists its state professional corporations — California, Colorado, New Jersey, Wisconsin, Puerto Rico — alongside Reliant MD Medical Associates PLLC; and every compounded product page, all eight microdose SKUs included, states that prescriptions are "fulfilled and shipped by our licensed pharmacy partner: Mycelium Pharmacy", which the privacy policy calls "our U.S.-licensed fulfillment pharmacy". You can look up who would prescribe and who would dispense before you hand over a card

The caveats

  • The headline is not a rate you can hold. The semaglutide card is titled "Monthly Plan", reads "Starting At $59 a month" and is subtitled "Best for flexibility" — while the banner across the top of the same page reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life". Nothing on the page reconciles the two, and there is no term selector to check
  • No standing month-to-month price is published for either compounded molecule, anywhere. Both plan buttons hand you to intake.wellmedr.com, an intake app that serves no price in its own HTML, so the figure you would actually be charged does not exist on the public site — you meet it after the medical intake
  • A "month" here is not a month, and the site gives two different answers about which one it is: the plan cards say medication is "shipped every 4 weeks", which is thirteen shipments a year, while the refund and cancellation policy says the subscription "will automatically renew every 21 days", which is more than seventeen. Either way you are billed more often than the monthly label implies
  • The microdose page headlines "ZERO Side Effects" and subheads "Zero side effct for 70%+ of members" (their typo). No compounded GLP-1 is side-effect-free, that page carries none of the thyroid warnings the pricing page does, and nausea and titration are exactly what a low-dose reader is trying to manage
  • One policy page states two different cancellation deadlines — "at least 48 hours prior to your scheduled renewal date" in one section and "at least 72 hours prior to your billing date" in another — and then says all subscription charges are final once processed. On a 21-day cycle, missing the window you did not know applied costs a full cycle
  • The pricing page's "MONEY BACK GUARANTEE — IF YOU DON'T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY!" is not the policy the refund page describes: that page limits refunds to the current billing cycle, and only while the medication has not yet been ordered
  • "Same price regardless of dosage" appears on the tirzepatide card only. The semaglutide card makes no such promise in either direction, so that molecule's dose basis is unstated rather than flat — ask before you titrate, and do not assume the tirzepatide line covers both
  • Six of the eight microdose SKUs publish no price at all. The two that do are both $199/month — more than three times the advertised semaglutide headline — so the low-dose line a reader came for is mostly unpriced, and the part that is priced is the expensive part
  • Almost nothing on the site is written for women. Across all 72 URLs in WellMedr's own sitemap, read on 2026-08-10, menopause and perimenopause appear zero times and PCOS appears twice — both of them the same boilerplate "Clinical Insight" paragraph about inositol research, pasted onto two microdose product pages that also carry, unedited, a line about standing behind "our male enhancement formula". The weight-loss program is real; the hormonal framing is not there
  • It will not say where it operates: the FAQ answers "What states do you serve?" with "We are expanding rapidly — eligibility is checked during sign-up", so you cannot confirm it can treat you where you live until you are inside the intake. The pharmacy disclosure has the same shape: Mycelium Pharmacy is named on the product pages and in the privacy policy, but on none of the landers — the pricing page a buyer actually arrives on offers only "FDA-regulated pharmacies", which is a claim about the pharmacy's status and not about the compounded drug
  • The before-and-after testimonials are labeled, forty-four times over, "Inspired by real patient success stories in similar Telehealth programs" — that is, they are not WellMedr patients — and they run beneath "GLP-1 medications used by 1,000,000+ patients" and video endorsements from Dr. Nowzaradan and Kevin O'Leary

The bottom line

Best for: Women who want a low-dose or needle-free way into a GLP-1 and will trade price certainty for that menu — and who will read the billing policy before the second charge lands, because the renewal cycle is not the month the pricing page implies. A genuinely broad low-dose menu — eight microdose formulations, four of them oral, on top of both injectable molecules and a priced brand path — wrapped around a price you cannot pin down: the $59 and $99 headlines are conditional, and the rate you would actually be charged month to month appears nowhere before the medical intake.

Ranked #58 of 65 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Cancellation fairness is where WellMedr scores lowest, at 52/100. If that is your sticking point, start with what women pick instead of WellMedr.

Compare with other providers

All 64 other providers we've reviewed for women, in our overall ranking order. One of those comparisons is written out in full: WellMedr against CoreAge Rx, factor by factor, 26 points apart on the Luna Fit Score. Directly below WellMedr sits Cielo at #59 with 73/100 — see the alternatives to Cielo we rank for women if that is the band you are shopping in.

Pricing, states and verification reflect WellMedr's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on WellMedr's site. Not medical advice; see our disclosure.

← Back to all providers